ProShare Advisors’s Regulus Therapeutics RGLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-13,671
| Closed | -$23.9K | – | 2168 |
|
|
2025
Q1 | $23.9K | Sell |
13,671
-4,114
| -23% | -$5.43K | ﹤0.01% | 2026 |
|
|
2024
Q4 | $28.1K | Buy |
17,785
+5,853
| +49% | +$8.99K | ﹤0.01% | 2238 |
|
|
2024
Q3 | $18.7K | Buy |
+11,932
| New | +$19.7K | ﹤0.01% | 2046 |
|
|
2016
Q4 | – | Sell |
-310
| Closed | -$123K | – | 1751 |
|
|
2016
Q3 | $123K | Sell |
310
-57
| -16% | -$23.4K | ﹤0.01% | 1402 |
|
|
2016
Q2 | $127K | Buy |
367
+13
| +4% | +$9.31K | ﹤0.01% | 1496 |
|
|
2016
Q1 | $294K | Sell |
354
-31
| -8% | -$24.7K | ﹤0.01% | 1216 |
|
|
2015
Q4 | $403K | Buy |
385
+32
| +9% | +$32.1K | ﹤0.01% | 1141 |
|
|
2015
Q3 | $277K | Sell |
353
-16
| -4% | -$16.4K | ﹤0.01% | 1178 |
|
|
2015
Q2 | $486K | Buy |
369
+5
| +1% | +$8.07K | 0.01% | 1109 |
|
|
2015
Q1 | $740K | Buy |
364
+68
| +23% | +$148K | 0.01% | 995 |
|
|
2014
Q4 | $569K | Buy |
296
+64
| +28% | +$114K | 0.01% | 1132 |
|
|
2014
Q3 | $190K | Sell |
232
-43
| -16% | -$36.4K | ﹤0.01% | 1994 |
|
|
2014
Q2 | $265K | Sell |
275
-87
| -24% | -$74.6K | ﹤0.01% | 1994 |
|
|
2014
Q1 | $391K | Buy |
362
+203
| +128% | +$225K | ﹤0.01% | 2052 |
|
|
2013
Q4 | $141K | Buy |
+159
| New | +$137K | ﹤0.01% | 1281 |
|